Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Lodi

Showing results (31-40 of 101) with videos related to

Pageof 11
Sort By:
European Journal of Epidemiology|February 22, 2022
Predicting counterfactual risks under hypothetical treatment strategies: an application to HIVBarbra A Dickerman, Issa J Dahabreh, Krystal V Cantos, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 17, 2011
Time from human immunodeficiency virus seroconversion to reaching CD4+ cell count thresholds <200, <350, and <500 Cells/mm³: assessment of need following changes in treatment guidelinesSara Lodi, Andrew Phillips, Giota Touloumi, et al.
JAMA Network Open|October 14, 2020
Association of Treatment With Medications for Opioid Use Disorder With Mortality After Hospitalization for Injection Drug Use-Associated Infective EndocarditisSimeon D Kimmel, Alexander Y Walley, Yijing Li, et al.
Journal of the International Association of Providers of AIDS Care|April 23, 2021
Emergency Department Utilization Among People Living With HIV on Chronic Opioid TherapyKinna Thakarar, Amoli Kulkarni, Sara Lodi, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 11, 2012
Rate of CD4 decline and HIV-RNA change following HIV seroconversion in men who have sex with men: a comparison between the Beijing PRIMO and CASCADE cohortsXiaojie Huang, Sara Lodi, Zoe Fox, et al.
Plos One|November 19, 2013
Symptomatic illness and low CD4 cell count at HIV seroconversion as markers of severe primary HIV infectionSara Lodi, Martin Fisher, Andrew Phillips, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 30, 2014
Evaluation of rapid progressors in HIV infection as an extreme phenotypeAshley D Olson, Marguerite Guiguet, Robert Zangerle, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 7, 2020
Higher Levels of Alcohol Use Are Associated With Latent Tuberculosis Infection in Adults Living With Human Immunodeficiency VirusSarah B Puryear, Robin Fatch, Brian Beesiga, et al.
Addiction (Abingdon, England)|January 30, 2023
Comprehensive needle and syringe program and opioid agonist therapy reduce HIV and hepatitis c virus acquisition among people who inject drugs in different settings: A pooled analysis of emulated trialsDaniela K van Santen, Sara Lodi, Paul Dietze, et al.
Arthritis Care & Research|September 22, 2025
Trends in Opioid Prescriptions in Individuals With Axial Spondyloarthritis in the United States and United Kingdom in the Last Two Decades: Analysis of Electronic Health Records and Insurance Claims DataH Berk Degirmenci, Christine E Peloquin, Maggie Westerland, et al.
Pageof 11

Showing results (31-40 of 101) with videos related to

Sort By:
Pageof 11
European Journal of Epidemiology|February 22, 2022
Predicting counterfactual risks under hypothetical treatment strategies: an application to HIVBarbra A Dickerman, Issa J Dahabreh, Krystal V Cantos, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 17, 2011
Time from human immunodeficiency virus seroconversion to reaching CD4+ cell count thresholds <200, <350, and <500 Cells/mm³: assessment of need following changes in treatment guidelinesSara Lodi, Andrew Phillips, Giota Touloumi, et al.
JAMA Network Open|October 14, 2020
Association of Treatment With Medications for Opioid Use Disorder With Mortality After Hospitalization for Injection Drug Use-Associated Infective EndocarditisSimeon D Kimmel, Alexander Y Walley, Yijing Li, et al.
Journal of the International Association of Providers of AIDS Care|April 23, 2021
Emergency Department Utilization Among People Living With HIV on Chronic Opioid TherapyKinna Thakarar, Amoli Kulkarni, Sara Lodi, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 11, 2012
Rate of CD4 decline and HIV-RNA change following HIV seroconversion in men who have sex with men: a comparison between the Beijing PRIMO and CASCADE cohortsXiaojie Huang, Sara Lodi, Zoe Fox, et al.
Plos One|November 19, 2013
Symptomatic illness and low CD4 cell count at HIV seroconversion as markers of severe primary HIV infectionSara Lodi, Martin Fisher, Andrew Phillips, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 30, 2014
Evaluation of rapid progressors in HIV infection as an extreme phenotypeAshley D Olson, Marguerite Guiguet, Robert Zangerle, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 7, 2020
Higher Levels of Alcohol Use Are Associated With Latent Tuberculosis Infection in Adults Living With Human Immunodeficiency VirusSarah B Puryear, Robin Fatch, Brian Beesiga, et al.
Addiction (Abingdon, England)|January 30, 2023
Comprehensive needle and syringe program and opioid agonist therapy reduce HIV and hepatitis c virus acquisition among people who inject drugs in different settings: A pooled analysis of emulated trialsDaniela K van Santen, Sara Lodi, Paul Dietze, et al.
Arthritis Care & Research|September 22, 2025
Trends in Opioid Prescriptions in Individuals With Axial Spondyloarthritis in the United States and United Kingdom in the Last Two Decades: Analysis of Electronic Health Records and Insurance Claims DataH Berk Degirmenci, Christine E Peloquin, Maggie Westerland, et al.
Pageof 11